5-Bromo-7-azaindole: A Crucial Pharmaceutical Intermediate for Cancer Therapy Synthesis
Unlock advanced cancer treatments with a key building block for pharmaceutical innovation.
Get a Quote & SampleProduct Core Value
5-Bromo-7-azaindole
As a vital 5-Bromo-7-azaindole pharmaceutical intermediate, this compound is essential for the synthesis of cutting-edge therapeutics, particularly in oncology. Its consistent quality ensures reliable outcomes in complex pharmaceutical synthesis.
- Leveraging high purity 5-Bromo-7-azaindole for enhanced drug efficacy. Our product meets stringent quality standards for critical pharmaceutical applications.
- Essential for Veliparib synthesis: This compound serves as a key building block in the 5-Bromo-7-azaindole synthesis of potent PARP inhibitors used in cancer therapy.
- CAS 183208-35-7 availability from trusted suppliers in China ensures a stable and dependable supply chain for your research and production needs.
- The versatile scaffold of 5-Bromo-7-azaindole makes it indispensable in medicinal chemistry for developing novel bioactive molecules.
Advantages Offered
Uncompromised Purity
With a purity of ≥99.0%, this 5-Bromo-7-azaindole guarantees reliable results in sensitive pharmaceutical synthesis processes, minimizing side reactions.
Critical Pharmaceutical Intermediate
Its role in the synthesis of cancer drugs like Veliparib highlights its importance, making it a sought-after material for drug discovery and development.
Stable Supply Chain
Sourced from reputable pharmaceutical intermediates suppliers in China, ensuring consistent availability and quality for bulk orders and ongoing research.
Key Applications
Pharmaceutical Synthesis
Used as a crucial intermediate in the synthesis of active pharmaceutical ingredients (APIs), particularly for anti-cancer drugs, enabling effective 5-Bromo-7-azaindole pharmaceutical intermediate utilization.
Drug Development
Essential for research and development of new therapeutic agents, allowing medicinal chemists to explore novel molecular structures and target specific diseases.
Medicinal Chemistry Research
The unique heterocyclic structure provides a versatile platform for various chemical reactions, aiding in the exploration of new drug candidates and chemical synthesis.
Oncology Therapeutics
Directly contributes to the production of life-saving treatments like Veliparib, a PARP inhibitor crucial in combating certain types of cancer.